Emerg Infect Dis. 2022 Mar;28(3):539-547. doi: 10.3201/eid2803.211467.
Enterovirus D68 (EV-D68) causes severe respiratory illness outbreaks among children, particularly those with asthma. We previously detected neutralizing antibodies against the predominant EV-D68 B1 clade in the 2014 outbreak in serum collected before the outbreak (2012–2013) from persons 24 months to 85 years of age. We recently detected neutralizing antibodies to the 2014 B1, B2, and D clade viruses in serum collected after the 2014 outbreak (April–May 2017) from 300 children 6 months to 18 years of age. B1 virus neutralizing antibodies were found in 100% of patients, even children born after 2014; B2 in 84.6%, and D in 99.6%. In 2017, titers increased with patient age and were higher than titers in 2012–2013 from comparably aged children. Rate of seronegativity was highest (15.3%) for B2 virus. Multivariate analysis revealed an association between asthma and higher titers against B2 and D viruses. EV-D68 seems to have circulated during 2014–2017.
肠道病毒 D68(EV-D68)可引起儿童严重呼吸道疾病暴发,尤其是哮喘患儿。我们之前在 2014 年疫情爆发前(2012-2013 年)采集的 24 个月至 85 岁人群血清中检测到针对主要 EV-D68 B1 分支的中和抗体。最近,我们在 2014 年疫情爆发后(2017 年 4-5 月)采集的 300 名 6 个月至 18 岁儿童血清中检测到针对 2014 年 B1、B2 和 D 分支病毒的中和抗体。B1 病毒中和抗体在所有患者中(甚至是 2014 年后出生的儿童)均为 100%阳性;B2 为 84.6%,D 为 99.6%。2017 年,抗体滴度随患者年龄增加而增加,且高于同期年龄相近儿童的 2012-2013 年抗体滴度。B2 病毒的血清阴性率最高(15.3%)。多变量分析显示哮喘与 B2 和 D 病毒的高滴度有关。EV-D68 似乎在 2014-2017 年期间传播。